Printer Friendly

VITAL HEART SYSTEMS ENTERS INTO EXCLUSIVE OPTION AGREEMENT TO PURCHASE NEW TECHNOLOGY

 VITAL HEART SYSTEMS ENTERS INTO EXCLUSIVE OPTION AGREEMENT
 TO PURCHASE NEW TECHNOLOGY
 BOSTON/MINNEAPOLIS, Oct. 22 /PRNewswire/ -- Vital Heart Systems, Inc. (NASDAQ: VHRT) announced today that it has entered into an exclusive option agreement with Dr. Schlomo Ben-Heim at the University of Iowa Hospitals and the Rappaport Family Institute for Research in the Medical Sciences, Israel, to purchase their technology and applications in the field of cardiology. Ben-Heim has committed to a long-term professional relationship with Vital Heart Systems to bring these new products to market.
 Ben-Heim, through his clinical research, has invented a method to measure the significance of electrophysiological stability in the heart. Ben-Heim has published this research in several medical journals, including the American Journal of Cardiology and Circulation. This technology and his invention greatly complement Vital Heart Systems' existing technology which is used to assist physicians in the diagnosis of coronary artery disease. Ben-Heim's new technology would allow for on-line monitoring of cardiac-related therapy.
 "This is an extremely exciting and important opportunity for Vital Heart Systems to advance its research efforts to bring new cardiac diagnostic and monitoring technology to market," said David L. Printy, chairman, president and CEO. "We are very pleased to work with such a talented medical professional with a common goal of introducing important medical technology."
 Vital Heart Systems, Inc., with offices in Beverly, Mass., and Minneapolis, manufactures and markets the variance cardiograph, a non- invasive, stress-free, diagnostic instrument to aid physicians in the diagnosis of coronary artery disease. The stock of Vital Heart Systems, Inc. is traded on the over-the-counter market under the NASDAQ symbol VHRT.
 -0- 10/22/92
 /CONTACT: David L. Printy, chairman, president, and CEO; or Deborah Meacock, director, investor relations, 1-800-966-2838, both for Vital Heart Systems/
 (VHRT) CO: Vital Heart Systems, Inc. ST: Minneapolis IN: MTC SU:


KH -- MN013 -- 3511 10/22/92 11:24 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 22, 1992
Words:309
Previous Article:AMERICAN MEDICAL ELECTRONICS REPORTS FINANCIAL RESULTS FOR THIRD QUARTER, FIRST NINE MONTHS OF 1992
Next Article:PARAMAX RECEIVES CONTRACT FOR COMBAT SYSTEM GROOMING FOR ALLIED NATION
Topics:


Related Articles
VITAL HEART SYSTEMS ANNOUNCES A JOINT CARDIOGRAPH DEVELOPMENT PROJECT WITH DIGITAL EQUIPMENT CORPORATION
STI LICENSES NEW PAIN PRODUCT TO LOTUS FOR HOME HEALTH CARE
VITAL HEART SYSTEMS ANNOUNCES LICENSING AGREEMENT
FRANKLIN OPHTHALMIC INSTRUMENTS CO., INC. ANNOUNCES DISTRIBUTION AGREEMENT
Versus Technology, Inc. Enters into Exclusive Marketing Agreement with Marquette Medical Systems

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters